CH514612A - Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine - Google Patents

Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine

Info

Publication number
CH514612A
CH514612A CH853970A CH853970A CH514612A CH 514612 A CH514612 A CH 514612A CH 853970 A CH853970 A CH 853970A CH 853970 A CH853970 A CH 853970A CH 514612 A CH514612 A CH 514612A
Authority
CH
Switzerland
Prior art keywords
oxazepines
diazepines
dibenzo
preparation
basic substituted
Prior art date
Application number
CH853970A
Other languages
English (en)
Inventor
Jean Dr Schmutz
Fritz Dr Hunziker
Martin Kuenzle Franz
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1470169A external-priority patent/CH481942A/de
Priority claimed from CH655767A external-priority patent/CH484924A/de
Priority claimed from CH1011567A external-priority patent/CH485752A/de
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Priority to CH751571A priority Critical patent/CH517759A/de
Priority to CH854070A priority patent/CH499539A/de
Priority to CH853970A priority patent/CH514612A/de
Priority claimed from CH220168A external-priority patent/CH499547A/de
Publication of CH514612A publication Critical patent/CH514612A/de
Priority claimed from US213709A external-priority patent/US3884920A/en
Priority claimed from US435430A external-priority patent/US3908010A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH853970A 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine CH514612A (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH751571A CH517759A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine
CH854070A CH499539A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine, Dibenzo(b,f)-1,4-thiazepine und Dibenzo(b,e)-1,4,diazepine
CH853970A CH514612A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine

Applications Claiming Priority (22)

Application Number Priority Date Filing Date Title
CH358267 1967-03-13
CH1470169A CH481942A (de) 1967-03-22 1967-03-22 Verfahren zur Herstellung basisch substituierter Heterocyclen
CH410367A CH481133A (de) 1967-03-22 1967-03-22 Verfahren zur Herstellung basisch substituierter Heterocyclen
CH1469969A CH481940A (de) 1967-03-22 1967-03-22 Verfahren zur Herstellung basisch substituierter Heterocyclen
CH1470069A CH481941A (de) 1967-03-22 1967-03-22 Verfahren zur Herstellung basisch substituierter Heterocyclen
CH655767A CH484924A (de) 1967-05-09 1967-05-09 Verfahren zur Herstellung basisch substituierter Heterocyclen
CH1101567 1967-07-14
CH1011567A CH485752A (de) 1967-07-14 1967-07-14 Verfahren zur Herstellung basisch substituierter Heterocyclen
CH1545367 1967-11-03
CH854070A CH499539A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine, Dibenzo(b,f)-1,4-thiazepine und Dibenzo(b,e)-1,4,diazepine
CH751571A CH517759A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine
CH220168A CH499547A (de) 1968-02-14 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenzo-(b,f)-1,4-thiazepin-5-oxide
CH853970A CH514612A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine
US76937368A 1968-10-21 1968-10-21
US79728169A 1969-02-06 1969-02-06
US5560370A 1970-07-16 1970-07-16
US5560270A 1970-07-16 1970-07-16
US5731770A 1970-07-22 1970-07-22
US19451571A 1971-11-01 1971-11-01
US21371071A 1971-12-29 1971-12-29
US213709A US3884920A (en) 1967-07-14 1971-12-29 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US435430A US3908010A (en) 1967-03-22 1974-01-22 Basically substituted heterocycles as anti-emetics

Publications (1)

Publication Number Publication Date
CH514612A true CH514612A (de) 1971-10-31

Family

ID=27586569

Family Applications (3)

Application Number Title Priority Date Filing Date
CH853970A CH514612A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine
CH751571A CH517759A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine
CH854070A CH499539A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine, Dibenzo(b,f)-1,4-thiazepine und Dibenzo(b,e)-1,4,diazepine

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH751571A CH517759A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine
CH854070A CH499539A (de) 1967-03-13 1968-02-14 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine, Dibenzo(b,f)-1,4-thiazepine und Dibenzo(b,e)-1,4,diazepine

Country Status (1)

Country Link
CH (3) CH514612A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101962369A (zh) 2003-12-22 2011-02-02 阿卡蒂亚药品公司 氨基取代的二芳基[a,d]环庚烯类似物作为毒蕈碱激动剂的用途及神经精神疾病的治疗方法
WO2010062565A1 (en) * 2008-10-27 2010-06-03 Acadia Pharmaceuticals Inc. Muscarinic agonists

Also Published As

Publication number Publication date
CH517759A (de) 1972-01-15
CH499539A (de) 1970-11-30

Similar Documents

Publication Publication Date Title
CH481937A (de) Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz(b,f)(1,4)oxazepin-11(10H)-onen
CH504459A (de) Verfahren zur Herstellung von Oxazepinen und Thiazepinen
CH496727A (de) Verfahren zur Herstellung von Oxazepinen und Thiazepinen
CH476016A (de) Verfahren zur Herstellung von neuen substituierten 10-(4-Methylpiperazino)-10,11-dihydrodibenzo-(b,f)-thiepinen
CH517759A (de) Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine
CH458355A (de) Verfahren zur Herstellung 11-aminoalkylierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,f)-1,4-thiazepine
CH473133A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
AT250975B (de) Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b, f][1, 4] oxazepine
AT292718B (de) Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon
CH420155A (de) Verfahren zur Herstellung von in 10-Stellung basisch substituierten Dibenz(b,f)(1,4)oxazepinon-Derivaten
CH502367A (de) Verfahren zur Herstellung von N-Aminoacyl-3,4-dihydro-(2H)-1,4-benzoxazinen
CH478812A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
AT283371B (de) Verfahren zur Herstellung von 1,3,4,5-Tetrahydro-1,4-benzodiazepinderivaten
CH460791A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
AT267530B (de) Verfahren zur Herstellung von 7-Chlor-1,3-dihydro-1-methyl-5-phenyl-2 H-1,4-benzodiazepin-2-on
CH531534A (de) Verfahren zur Herstellung neuer Dibenz(b,f)(1,4) oxazepin-Derivate
CH474528A (de) Verfahren zur Herstellung von 1-Methyl-7-halogen-2, 3-dihydro-5-phenyl-1,4-benzodiazepinen
AT278815B (de) Verfahren zur herstellung neuer 11-aminoalkylierter dibenz <b,f>-1,4-oxazepine und dibenzo <b,f>-1,4-thiazepine sowi
AT292722B (de) Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon
AT292721B (de) Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon
CH482709A (de) Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz(b,f)(1,4)oxazepin-11(10H)-onen
CH482692A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH484164A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
AT283370B (de) Verfahren zur Herstellung von 1,3,4,5-Tetrahydro- -2H-1,4-benzodiazepin-2-on-Derivaten
AT252926B (de) Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f][1,4]oxazepine

Legal Events

Date Code Title Description
PL Patent ceased